USA | New Draft FDA Guidance: Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products
Please login to view this page.
- USA | Draft FDA Guidance – Postmarketing Approaches to Obtain Data on Populations Underrepresented in Clinical Trials for Drugs and Biological Products Gallery
USA | Draft FDA Guidance – Postmarketing Approaches to Obtain Data on Populations Underrepresented in Clinical Trials for Drugs and Biological Products
USA | Draft FDA Guidance – Postmarketing Approaches to Obtain Data on Populations Underrepresented in Clinical Trials for Drugs and Biological Products
Please login to view this page.
UK | Increasing the Diversity of People Taking Part in Research
Please login to view this page.
EU | Reform of the EU Pharmaceutical Legislation
Please login to view this page.
CANADA | Promoting Diversity in Clinical Trials
Please login to view this page.
USA | FDA Takes Important Steps to Increase Racial and Ethnic Diversity in Clinical Trials
Please login to view this page.